ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SAI MULA MD

Neurology

625

$150K

118
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$241
Average prescription price

Avg: $218

PAMELA BLAKE MD

Neurology

620

$78K

78
47 are 65+

23%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$126
Average prescription price

Avg: $218

RICHARD SAWYERS

Neurology

619

$74.7K

65
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$121
Average prescription price

Avg: $218

AMBIKA NAIR MD

Neurology

619

$127K

126
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 28%

$206
Average prescription price

Avg: $218

ANDREA RAYMOND M.D.

Neurology

617

$55.2K

82
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $218

JEANETTE HARTSHORN PHD

Neurology

615

$75.8K

51
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$123
Average prescription price

Avg: $218

STEVEN HERZOG M.D.

Neurology

615

$48.6K

153
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$79
Average prescription price

Avg: $218

THOMAS MITCHELL MD

Neurology

614

$93.6K

40
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$152
Average prescription price

Avg: $218

BRITT DANIEL M.D.

Neurology

608

$157K

82
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$258
Average prescription price

Avg: $218

TA NGUYEN MD

Neurology

605

$238K

75
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$394
Average prescription price

Avg: $218

JERALD SIMMONS MD

Neurology

604

$117K

118
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$193
Average prescription price

Avg: $218

JEFFREY JACKSON M.D.

Neurology

596

$98.6K

107
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$165
Average prescription price

Avg: $218

CLIFFORD FRAIM M.D.

Neurology

596

$103K

153
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$173
Average prescription price

Avg: $218

MUHAMMAD KHAN M.D.

Neurology

594

$130K

102
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$219
Average prescription price

Avg: $218

MARIANA VARGA MD

Neurology

588

$186K

65
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 28%

$316
Average prescription price

Avg: $218

JAI KUMAR M.D.

Neurology

584

$55.7K

130
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$95
Average prescription price

Avg: $218

GAGE VAN HORN M.D.

Neurology

581

$134K

85
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 28%

$231
Average prescription price

Avg: $218

JAYA TRIVEDI MD

Neurology

580

$65K

84
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$112
Average prescription price

Avg: $218

MONTGOMERY VERONA M.D.

Neurology

578

$50.6K

101
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$88
Average prescription price

Avg: $218

ZIMBUL ALBO M.D.

Neurology

574

$174K

111
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 28%

$304
Average prescription price

Avg: $218

YANKO YANKOV M.D.

Neurology

574

$179K

83
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 28%

$311
Average prescription price

Avg: $218

ELISABETH SCHMALSTIEG M.D.

Neurology

570

$74.7K

79
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 28%

$131
Average prescription price

Avg: $218

AZIZ SHAIBANI MD

Neurology

567

$195K

122
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 28%

$344
Average prescription price

Avg: $218

MAUREEN WATTS MD

Neurology

566

$148K

70
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$262
Average prescription price

Avg: $218

EDWIN GREEN M.D.

Neurology

560

$217K

56
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$387
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank